Nuchal translucency and the acceptance of invasive prenatal chromosomal diagnosis in women aged 35 and older

Obstetrics and Gynecology

Volumn 97, Issue 6, 2001, Pages 916-920

  Zoppi, Maria A ^a   Ibba, Rosa M ^a   Putzolu, Monica ^a   Floris, Marcella ^a   Monni, Giovanni ^a  

^a Osp Regionale per le Microcitemie   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AMNIOCENTESIS; ARTICLE; CHORION VILLUS SAMPLING; CHROMOSOME ABERRATION; DIAGNOSTIC PROCEDURE; FEMALE; FETUS ECHOGRAPHY; GENETIC COUNSELING; GESTATIONAL AGE; HUMAN; INFORMED CONSENT; KARYOTYPING; MAJOR CLINICAL STUDY; PATIENT ATTITUDE; PRENATAL DIAGNOSIS; PRIORITY JOURNAL;

ABORTION, THERAPEUTIC; ADULT; AMNIOCENTESIS; CHORIONIC VILLI SAMPLING; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; FEMALE; GENETIC SCREENING; HUMANS; ITALY; MATERNAL AGE; MIDDLE AGED; NECK; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT COMPLIANCE; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PRENATAL DIAGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 0034987147     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(01)01381-3     Document Type: Article

References (33)

1. Proceedings of the EUROCROMIC workshop on prenatal diagnosis
2. Prenatal diagnosis in Italy
3. Diagnosi invasiva: Villocentesi
4. A method of sampling chorionic villi in first trimester of pregnancy under guidance of realtime ultrasound
5. Comparison of chorionic villus sampling and amniocentesis for fetal karyotyping at 10-13 weeks' gestation
6. Transabdominal chorionic villus sampling: A freehand ultrasound guided technique
7. Chorion villus sampling: Introduction and techniques
8. Fetal nuchal translucency screening for chromosomal defects in first trimester of pregnancy
9. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation
10. Screening for Down's syndrome by fetal nuchal translucency measurement in general obstetric population
11. Assessment of risk for chromosomal abnormalities at 10-14 weeks of gestation by nuchal translucency and maternal age in 5,210 fetuses carried out at a single center
12. Evaluation of first-trimester screening by fetal nuchal translucency and maternal age
13. Screening for Down syndrome by fetal nuchal translucency measurement in a high-risk population
14. Acceptability of serum screening as an alternative to cytogenetic diagnosis of Down syndrome among women 35 years or older in Hong Kong
15. Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening
16. Integrated screening for Down's syndrome based on tests performed during the first and second trimester
17. Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation
18. Randomised comparison of amniocentesis and transabdominal and transcervical chorionic villus sampling
19. Randomised controlled trial of genetic amniocentesis in 4,606 low-risk women
20. Limb defects and chorionic villus sampling results from an international registry 1992-94
21. Transabdominal chorionic villus sampling: Fetal loss in relation to maternal and gestational age
22. An economic evaluation of first-trimester genetic sonography for prenatal detection of Down syndrome
23. Cost-benefit analysis of prenatal diagnosis for Down syndrome using the British or the American approach
24. Early transabdominal chorionic villus sampling in couples at high genetic risk
25. Should all pregnant patients be offered prenatal diagnosis regardless of age?
26. Chorionic villus sampling and acceptance rate of prenatal diagnosis
27. Selective miscarriage of Down's syndrome fetuses in women aged 35 and older
28. Maternal age- and gestation-specific risk for trisomy 21
29. Termination rates after prenatal diagnosis of Down syndrome, spina bifida, anencephaly, and Turner and Klinefelter syndromes: A systematic literature review
30. Mid-gestational abortion for medical or genetic indications
31. Second trimester abortions: Trends and medical complications